TP53 and ovarian carcinoma: The quantification of Ir in isolated nuclear DNA fractions revealed that that the Ir-bound content in A2780 ovarian cancer cells (wild-type p53) treated with complex 43 was at least 13-times higher than in cells treated with cisplatin.